REQUEST A DEMO
Total
USD $0.00
Search more companies

Hyphens Pharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores | All Other Miscellaneous Ambulatory Health Care Services
Full name: Hyphens Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Hyphens Pharma Sdn. Bhd. is an enterprise in Malaysia, with the main office in Petaling Jaya. The company operates in the Pharmacies and Drug Stores industry. Hyphens Pharma Sdn. Bhd. was incorporated on January 31, 2004. In 2022, the company reported a net sales revenue increase of 40.4%. Its total assets grew by 15.77% over the same period. The net profit margin of Hyphens Pharma Sdn. Bhd. increased by 1.12% in 2022.

Headquarters
L1-10 & L1-11, Pj Midtown, Jalan Kemajuan, Seksyen 13
Petaling Jaya; Selangor; Postal Code: 46200

Contact Details: Purchase the Hyphens Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Hyphens Pharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Hyphens Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Hyphens Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
January 31, 2004
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hyphens Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
40.4%
Total operating revenue
40.4%
Operating profit (EBIT)
77.82%
EBITDA
73.01%
Net Profit (Loss) for the Period
59.34%
Total assets
15.77%
Total equity
52.69%
Operating Profit Margin (ROS)
3%
Net Profit Margin
1.12%
Return on Equity (ROE)
1.44%
Debt to Equity Ratio
-1.71%
Quick Ratio
0.44%
Cash Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?